Financial Information

ASX Filing.

Date Price sens. Headline pages PDF
20/08/2019 ! Appendix 4E & 2019 Full Year Statutory Accounts 83 PDF
13/08/2019   Ceasing to be a substantial holder from AEF 3 PDF
09/08/2019   Change in substantial holding 5 PDF
07/08/2019   Change of Director's Interest Notice - Mr Chamberlain 2 PDF
07/08/2019   Change of Director's Interest Notice - Mr Voigt 2 PDF
06/08/2019   Immutep completes fully underwritten A$6M Entitlement Offer 2 PDF
01/08/2019 ! Entitlement Offer Results & Shortfall Notification 2 PDF
26/07/2019 ! Operational Update 4 PDF
26/07/2019 ! Appendix 4C - quarterly 5 PDF
19/07/2019   Becoming a substantial holder from AEF 3 PDF
19/07/2019   Change in substantial holding 6 PDF
17/07/2019   Mailing of Offer Booklet for Entitlement Offer 1 PDF
17/07/2019   Cleansing Notice 1 PDF
17/07/2019  
Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)
1 PDF
09/07/2019  
Cleansing Notice
1 PDF
09/07/2019  
Letter to Ineligible Shareholders
2 PDF
09/07/2019  
Letter to Eligible Shareholders
3 PDF
09/07/2019  
Appendix 3B
14 PDF
09/07/2019 !
Immutep Entitlement Offer Booklet
56 PDF
09/07/2019 !
Immutep Capital Raising Presentation
27 PDF
09/07/2019 !
Immutep raises A$10M via placement & entitlement offer
4 PDF
05/07/2019 ! 2 PDF
25/06/2019 !
Immutep completes recruitment of AIPAC trial in MBC
3 PDF
25/06/2019  
Immutep hosts Key Opinion Leader Call
2 PDF
21/06/2019 !
Immutep granted Australian patent for eftilagimod alpha
2 PDF
13/06/2019 ! 2 PDF
06/06/2019 ! 3 PDF
03/06/2019   14 PDF
03/06/2019  
Immutep Poster Presentation at ASCO
3 PDF
23/05/2019 ! 2 PDF
17/05/2019 ! 2 PDF
10/05/2019   2 PDF
08/05/2019   67 PDF
30/04/2019 ! 4 PDF
24/04/2019 ! 5 PDF
02/04/2019   29 PDF
27/03/2019   2 PDF
26/03/2019   10 PDF
25/03/2019   13 PDF
22/03/2019 ! 2 PDF
19/03/2019   2 PDF
08/03/2019 ! 2 PDF
07/03/2019 ! 1 PDF
06/03/2019 ! 4 PDF
06/03/2019 ! 3 PDF
04/03/2019   2 PDF
27/02/2019   29 PDF
26/02/2019   2 PDF
25/02/2019   18 PDF
31/01/2019   14 PDF
24/01/2019 !
Appendix 4C - quarterly
5 PDF
07/01/2019 ! 3 PDF
04/01/2019   3 PDF
04/01/2019   4 PDF
02/01/2019  
Appendix 3B
 15 PDF
24/12/2018   Becoming a substantial holder 4 PDF
21/12/2018   Disclosure Under LR 3.10.5A and 7.1A.4(b) 2 PDF
21/12/2018   Cleansing Notice 1 PDF
21/12/2018   Appendix 3B 14 PDF
20/12/2018 ! Cleansing prospectus for issue of warrants 46 PDF
19/12/2018 ! Immutep announces US$5.2 million capital raising 3 PDF
29/11/2018 ! European patent granted for IMP321 & antibody combinations 2 PDF
28/11/2018 ! Immutep granted European patent for IMP321 2 PDF
27/11/2018 ! Immutep presents new TACTI-mel data at ICI Europe Summit 3 PDF
26/11/2018   Change of Director's Interest Notice - Dr Howard 2 PDF
21/11/2018   Appendix 3B 14 PDF
16/11/2018   Results of Meeting 3 PDF
16/11/2018   2018 AGM CEO Presentation 23 PDF
16/11/2018   2018 AGM Chairman's Address 3 PDF
12/11/2018 ! Positive interim TACTI-mel data presented at SITC 3 PDF
01/11/2018 ! Operational Update 4 PDF
30/10/2018   AusBiotech Invest presentation slides 11 PDF
25/10/2018 ! Appendix 4C - quarterly 5 PDF
22/10/2018   Annual Report filed on Form 20-F with SEC 127 PDF
11/10/2018   Notice of Annual General Meeting/Proxy Form 27 PDF
11/10/2018   Annual Report to shareholders 80 PDF
11/10/2018   Appendix 4G & Corporate Governance Statement 32 PDF
04/10/2018   Appendix 3B & cleansing notice 15 PDF
02/10/2018   Change of Director's Interest Notice - Mr Chamberlain 3 PDF
02/10/2018   Change of Director's Interest Notice - Mr Meyers 3 PDF
02/10/2018   Appendix 3B & cleansing notice 15 PDF
02/10/2018   Ceasing to be a substantial holder from AEF 3 PDF
02/10/2018   Immutep to present at SITC 2018 2 PDF
28/09/2018   Appendix 3B & cleansing notice 14 PDF
27/09/2018   Appendix 3B & cleansing notice 14 PDF
27/09/2018   Change in substantial holding from AEF 3 PDF
26/09/2018   Immutep to present at Ladenburg Thalmann conference 1 PDF
24/09/2018 ! Immutep enters into collaboration with Pfizer & Merck KGaA 4 PDF
07/09/2018   Immutep presentation for BioCentury NewsMakers conference 29 PDF
03/09/2018   Change in substantial holding from AEF 3 PDF
03/09/2018 ! Progress towards clinical development of IMP761 2 PDF
21/08/2018 ! Appendix 4E & 2018 Full Year Statutory Accounts 82 PDF
21/08/2018 ! Immutep receives A$1.9M from French R&D tax cash rebate 2 PDF
16/08/2018   Immutep to present at BioCentury NewsMakers conference 2 PDF
07/08/2018 ! Immutep secures Canadian patent grant for IMP731 antibody 2 PDF
07/08/2018 ! TACTI-mel Patient Recruitment Complete & Operational Update 3 PDF
31/07/2018 ! Immutep receives IND approval from US FDA for IMP321 2 PDF
30/07/2018 ! Appendix 4C - quarterly 5 PDF
02/07/2018 ! Immutep submits IND application with FDA 2 PDF
19/06/2018   Investor Update 13 PDF
19/06/2018 ! Mid-point of patient enrolment reached in AIPAC trial 2 PDF
04/06/2018   Immutep Poster Presentations at ASCO 2 PDF
30/05/2018 ! Webcast slides for TACTI-mel clinical trial data 25 PDF
30/05/2018 ! New Data from Ongoing TACTI-mel Study 2 PDF
25/05/2018   3rd Annual Advances in Immuno-Oncology Congress Presentation 37 PDF
17/05/2018   Webcast to discuss interim results from TACTI-mel 3 PDF
15/05/2018   Response to ASX Price Query 3 PDF
04/05/2018   Immutep to present at ASCO 2 PDF
23/04/2018   Appendix 4C 5 PDF
13/04/2018   Appendix 3B 13 PDF
13/04/2018   Completion of Share Purchase Plan 2 PDF
03/04/2018 ! Operational Update 2 PDF

 

SEC Filing.

Date Filing Description Link
2019-08-14 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-220211 (34 Act) Size: 10 MB
PDF
2019-08-14 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-220204 (34 Act) Size: 52 KB
PDF-2
2019-08-14 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-220204 (34 Act) Size: 52 KB
PDF-1
2019-08-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-214347 (34 Act) Size: 26 KB
PDF
2019-07-30 D Notice of Exempt Offering of Securities, item 06b
Acc-no: 0001209191-19-043598 (33 Act) Size: 8 KB
PDF
2019-07-30 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-206095 (34 Act) Size: 113 KB
PDF
2019-07-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-189823 (34 Act) Size: 68 KB
PDF
2019-06-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-181460 (34 Act) Size: 31 KB
PDF
2019-06-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-178045 (34 Act) Size: 32 KB
PDF
2019-06-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-171778 (34 Act) Size: 26 KB
PDF
2019-06-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-165320 (34 Act) Size: 27 KB
PDF
2019-06-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-165318 (34 Act) Size: 162 KB
PDF
2019-05-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-154569 (34 Act) Size: 22 KB
PDF
2019-05-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-150736 (34 Act) Size: 25 KB
PDF
2019-05-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-144945 (34 Act) Size: 36 KB
PDF
2019-05-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-130751 (34 Act) Size: 39 KB
PDF
2019-04-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-120345 (34 Act) Size: 102 KB
PDF
2019-04-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-095885 (34 Act) Size: 11 MB
PDF
2019-03-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-089166 (34 Act) Size: 30 KB
PDF
2019-03-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-085849 (34 Act) Size: 4 MB
PDF
2019-03-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-079827 (34 Act) Size: 31 KB
PDF
2019-03-11 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-070282 (34 Act) Size: 33 KB
PDF
2019-03-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-065913 (34 Act) Size: 45 KB
PDF
2019-03-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-065883 (34 Act) Size: 39 KB
PDF
2019-03-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-062670 (34 Act) Size: 46 KB
PDF
2019-02-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-055085 (34 Act) Size: 486 KB
PDF
2019-02-27 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-052155 (34 Act) Size: 27 KB
PDF
2019-02-27 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-050316 (34 Act) Size: 5 MB
PDF
2019-02-14 424B3 Prospectus [Rule 424(b)(3)]
Acc-no: 0001193125-19-038345 (33 Act) Size: 337 KB
PDF
2019-02-12 EFFECT Notice of Effectiveness
Acc-no: 9999999995-19-000221 (33 Act) Size: 1 KB
PDF
2019-02-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-027147 (34 Act) Size: 2 MB
PDF
2019-01-14 F-3 Registration statement by foreign private issuers
Acc-no: 0001193125-19-008155 (33 Act) Size: 380 KB
PDF
2019-01-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-004095 (34 Act) Size: 41 KB
PDF
2019-01-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-19-000902 (34 Act) Size: 146 KB
PDF
2018-12-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-356488 (34 Act) Size: 305 KB
PDF
2018-12-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-356410 (34 Act) Size: 168 KB
PDF-1, PDF-2, PDF-3
2018-12-21 D Notice of Exempt Offering of Securities, item 06b
Acc-no: 0001209191-18-063797 (33 Act) Size: 10 KB
PDF
2018-12-19 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-352838 (34 Act) Size: 27 KB
PDF
2018-12-19 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-352630 (34 Act) Size: 490 KB
PDF-1, PDF-2, PDF-3, PDF-4
2018-12-19 424B5 Prospectus [Rule 424(b)(5)]
Acc-no: 0001193125-18-352623 (33 Act)  Size: 488 KB
PDF
2018-11-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-335585 (34 Act) Size: 32 KB
PDF
2018-11-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-335435 (34 Act) Size: 36 KB
PDF
2018-11-27 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-334115 (34 Act) Size: 27 KB
PDF
2018-11-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Acc-no: 0001193125-18-332532 (34 Act) Size: 193 KB PDF
2018-11-19 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-329689 (34 Act) Size: 39 KB
PDF
2018-11-19 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-329687 (34 Act) Size: 8 MB
PDF-2
2018-11-19 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-329687 (34 Act) Size: 8 MB
PDF-1
2018-11-16 CT ORDER Confidential treatment order Acc-no: 9999999997-18-009006 (34 Act) Size: 105 KB PDF
2018-11-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-324662 (34 Act) Size: 38 KB
PDF
2018-11-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-319727 (34 Act) Size: 33 KB
PDF
2018-10-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-312572 (34 Act) Size: 4 MB
PDF
2018-10-26 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-308011 (34 Act) Size: 102 KB
PDF
2018-10-25 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-306696 (34 Act) Size: 34 KB
PDF
2018-10-19 20-F Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-302492 (34 Act) Size: 581 KB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300562 (34 Act) Size: 888 KB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300478 (34 Act) Size: 15 MB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300442 (34 Act) Size: 247 KB
PDF
2018-10-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-293981 (34 Act) Size: 127 KB
PDF
2018-10-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-292668 (34 Act) Size: 184 KB
PDF-1 PDF-2 PDF-3
2018-10-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-292527 (34 Act) Size: 119 KB
PDF
2018-10-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-291188 (34 Act) Size: 23 KB
PDF
2018-10-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-288121 (34 Act) Size: 118 KB
PDF
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285992 (34 Act) Size: 114 KB
PDF-2
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285992 (34 Act) Size: 114 KB
PDF-1
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285955 (34 Act) Size: 28 KB
PDF
2018-09-10 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-269333 (34 Act) Size: 2 MB
PDF
2018-09-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-266455 (34 Act) Size: 34 KB
PDF
2018-08-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-256678 (34 Act) Size: 1 MB 
PDF-2
2018-08-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-256678 (34 Act) Size: 1 MB
PDF-1
2018-08-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-251021 (34 Act) Size: 21 KB
PDF
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB 
PDF-2
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB
PDF-1
2018-08-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-233634 (34 Act) Size: 24 KB
PDF
2018-07-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-232248 (34 Act) Size: 108 KB
PDF
2018-07-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-211709 (34 Act) Size: 35 KB
PDF
2018-06-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-197123 (34 Act) Size: 3 MB
PDF-1
PDF-2
2018-06-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-183678 (34 Act) Size: 34 KB
PDF
2018-05-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-179361 (34 Act) Size: 10 MB
PDF-1 PDF-2
2018-05-30 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-177481 (34 Act) Size: 9 MB
PDF
2018-05-18 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-166845 (34 Act) Size: 33 KB
PDF
2018-05-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-153820 (34 Act) Size: 32 KB
PDF
2018-04-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-131968 (34 Act) Size: 117 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117066 (34 Act) Size: 21 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117059 (34 Act) Size: 115 KB
PDF
2018-04-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-106513 (34 Act) Size: 29 KB
PDF